Forward shuttered after raising $650 million for its AI doc-in-a-box. This is the definitive story of how the healthcare ...

Infosys Knowledge Institute, a research arm of Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in ...

Mizuho Securities analyst John Baumgartner has maintained their bullish stance on MDLZ stock, giving a Buy rating on November 6. John ...

Adam Jonas, an analyst from Morgan Stanley, maintained the Buy rating on Tesla (TSLA – Research Report). The associated price target ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...